ScholarLens Back to search
2003•American Association of Bovine Practitioners Conference ProceedingsOpen access

Minimum Inhibitory Concentrations for Ceftiofur and Comparator Antimicrobial Agents against Bacterial Pathogens of Veterinary Importance to Cattle from 1997 to 2001

Sarah A. Salmon, Ellen S. Portis, C. J. Lindeman

Open full text 0 citations

Abstract

Ceftiofur is an extended spectrum cephalosporin antimicrobial agent that was developed solely for veterinary therapeutic use, and was first approved for the treatment of bovine respiratory disease (BRD) in 1988 by the FDA-CVM. In 1997 Pharmacia Animal Health (PAH) initiated a target pathogen susceptibility monitoring program, and continues to monitor the in vitro activity of ceftiofur as well as other antimicrobials used in the treatment of BRD. This paper discusses the results of monitoring the sensitivity of BRD isolates to ceftiofur over the last four years.

Open-access reader

About this research paper

What this paper is about

Ceftiofur is an extended spectrum cephalosporin antimicrobial agent that was developed solely for veterinary therapeutic use, and was first approved for the treatment of bovine respiratory disease (BRD) in 1988 by the FDA-CVM. In 1997 Pharmacia Animal Health (PAH) initiated a target pathogen susceptibility monitoring program, and continues to monitor the in vitro activity of ceftiofur as well as other antimicrobials used in the treatment of BRD. This paper discusses the results of monitoring the sensitivity of BRD isolates to ceftiofur over the last four years.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ceftiofur is an extended spectrum cephalosporin antimicrobial agent that was developed solely for veterinary therapeutic use, and was first approved for the treatment of bovine respiratory disease (BRD) in 1988 by the FDA-CVM. In 1997 Pharmacia Animal Health (PAH) initiated a target pathogen susceptibility monitoring program, and continues to monitor the in vitro activity of ceftiofur as well as other antimicrobials used in the treatment of BRD. This paper discusses the results of monitoring the sensitivity of BRD isolates to ceftiofur over the last four years.

Key concepts: Ceftiofur, Antimicrobial, Bovine respiratory disease, Cephalosporin, Veterinary medicine, Minimum inhibitory concentration, Medicine, Microbiology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Minimum Inhibitory Concentrations for Ceftiofur and Comparator Antimicrobial Agents against Bacterial Pathogens of Veterinary Importance to Cattle from 1997 to 2001 — Research Paper | ScholarLens